Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / Common Stock, $0.00000002 par value
-
Shares outstanding
-
29.5M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
22.7M
-
Shares change
-
+8.38M
-
Total reported value, excl. options
-
$96.9M
-
Value change
-
+$35.7M
-
Put/Call ratio
-
0
-
Number of buys
-
30
-
Number of sells
-
-7
-
Price
-
$4.27
Significant Holders of MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) as of Q4 2014
54 filings reported holding MEIP - MEI Pharma, Inc. - Common Stock, $0.00000002 par value as of Q4 2014.
MEI Pharma, Inc. - Common Stock, $0.00000002 par value (MEIP) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.7M shares
of 29.5M outstanding shares and own 76.81% of the company stock.
Largest 10 shareholders include FMR LLC (4.24M shares), DEERFIELD MANAGEMENT CO (2.94M shares), FRANKLIN RESOURCES INC (2.59M shares), ORBIMED ADVISORS LLC (2.42M shares), Point72 Asset Management, L.P. (1.65M shares), New Leaf Venture Partners, L.L.C. (1.6M shares), Visium Asset Management, LP (1.02M shares), JPMORGAN CHASE & CO (757K shares), VANGUARD GROUP INC (688K shares), and MILLENNIUM MANAGEMENT LLC (674K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.